Innate Pharma S.A. IPHA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -82.34% | -80.64% | -51.83% | -55.31% | -28.33% |
| Total Receivables | 270.53% | 306.34% | 425.35% | 387.31% | -90.46% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -15.83% | -7.71% | -4.01% | -10.95% | -21.65% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 37.57% | 50.86% | 435.14% | 396.44% | -40.84% |
| Total Current Assets | -70.66% | -67.82% | -38.22% | -42.69% | -36.18% |
|
|
|||||
| Total Current Assets | -70.66% | -67.82% | -38.22% | -42.69% | -36.18% |
| Net Property, Plant & Equipment | -28.48% | -21.57% | -3.76% | -10.73% | -5.52% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -92.26% | -91.52% | -86.28% | -87.27% | -41.63% |
| Total Assets | -63.65% | -60.14% | -35.95% | -40.59% | -32.76% |
|
|
|||||
| Total Accounts Payable | 16.07% | 27.28% | 7.00% | -0.75% | -43.00% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.49% | 28.84% | 14.62% | 6.32% | 9.67% |
| Total Finance Division Other Current Liabilities | 1.52% | 11.33% | 41.31% | 31.08% | -14.95% |
| Total Other Current Liabilities | 1.52% | 11.33% | 41.31% | 31.08% | -14.95% |
| Total Current Liabilities | 8.62% | 19.11% | 26.02% | 16.89% | -15.62% |
|
|
|||||
| Total Current Liabilities | 8.62% | 19.11% | 26.02% | 16.89% | -15.62% |
| Long-Term Debt | -49.19% | -44.28% | -30.09% | -35.15% | -25.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -71.63% | -68.93% | 5.76% | -1.90% | 0.91% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -20.38% | -12.69% | -17.88% | -23.82% | -23.77% |
| Total Liabilities | -16.64% | -8.58% | -6.34% | -13.12% | -21.58% |
|
|
|||||
| Common Stock & APIC | -2.22% | 7.23% | 18.44% | 9.87% | 15.66% |
| Retained Earnings | -8.60% | -19.09% | -27.84% | -18.59% | -23.56% |
| Treasury Stock & Other | -29.53% | -22.72% | 4,588.21% | 4,257.81% | 268.61% |
| Total Common Equity | -866.07% | -940.05% | -378.63% | -358.46% | -80.42% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -866.07% | -940.05% | -378.63% | -358.46% | -80.42% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -866.07% | -940.05% | -378.63% | -358.46% | -80.42% |
|
|
|||||